Summarized by Masters of Longevity from Longevity Technology.
A biotech-company profile about launching a limited-run longevity skincare product to finance its drug-research pipeline, inviting readers curious about industry strategies and science-backed fundraising.
Key Takeaways
- The company launched a consumer skincare brand with a $120 anti-aging moisturizer available for pre-order.
- Initial production is limited to 500 units and profits will be reinvested into the company's drug programs.
- The moisturizer is framed around the company's research on IF1 protein and mouse data linking increased IF1 to reduced aging biomarkers.
